{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:16:40Z","timestamp":1791919000784,"version":"4.3.4"},"reference-count":263,"publisher":"Elsevier","isbn-type":[{"value":"9780128152065","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.acc.2017.12.002","type":"book-chapter","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T20:26:06Z","timestamp":1517516766000},"page":"39-79","source":"Crossref","is-referenced-by-count":46,"title":["Inflammatory Response During Myocardial Infarction"],"prefix":"10.1016","member":"78","reference":[{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb0010","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0735-1097(01)01711-9","article-title":"The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis","volume":"39","author":"Burns","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/bs.acc.2017.12.002_bb0020","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jacc.2004.06.071","article-title":"The quantification of infarct size","volume":"44","author":"Gibbons","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/bs.acc.2017.12.002_bb0025","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2007.06.057","article-title":"Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial","volume":"50","author":"de Lemos","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/bs.acc.2017.12.002_bb0030","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/HCO.0000000000000158","article-title":"Inflammation in cardiac injury, repair and regeneration","volume":"30","author":"Frangogiannis","year":"2015","journal-title":"Curr. Opin. Cardiol."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/bs.acc.2017.12.002_bb0045","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6917","key":"10.1016\/bs.acc.2017.12.002_bb0050","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"7407","key":"10.1016\/bs.acc.2017.12.002_bb0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature11260","article-title":"Myocardial infarction accelerates atherosclerosis","volume":"487","author":"Dutta","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0060","first-page":"305","article-title":"Systemic inflammatory response following acute myocardial infarction","volume":"12","author":"Fang","year":"2015","journal-title":"J. Geriatr. Cardiol."},{"issue":"12","key":"10.1016\/bs.acc.2017.12.002_bb0065","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/ATVBAHA.111.224907","article-title":"Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease","volume":"31","author":"Zheng","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/14728222.2016.1088005","article-title":"Targeting danger-associated molecular patterns after myocardial infarction","volume":"20","author":"van Hout","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0075","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/eji.200424916","article-title":"Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator","volume":"34","author":"Erlandsson Harris","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molimm.2012.10.037","article-title":"HMGB1 and leukocyte migration during trauma and sterile inflammation","volume":"55","author":"Venereau","year":"2013","journal-title":"Mol. Immunol."},{"issue":"6894","key":"10.1016\/bs.acc.2017.12.002_bb0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/joim.12276","article-title":"High-mobility group box-1 in sterile inflammation","volume":"276","author":"Tsung","year":"2014","journal-title":"J. Intern. Med."},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","article-title":"The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway","volume":"3","author":"Gardella","year":"2002","journal-title":"EMBO Rep."},{"issue":"51","key":"10.1016\/bs.acc.2017.12.002_bb0100","doi-asserted-by":"crossref","first-page":"39888","DOI":"10.1074\/jbc.M110.128348","article-title":"High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity","volume":"285","author":"Evankovich","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","author":"Schiraldi","year":"2012","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10456-008-9093-5","article-title":"Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)","volume":"11","author":"van Beijnum","year":"2008","journal-title":"Angiogenesis"},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb0115","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1074\/jbc.M306793200","article-title":"Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein","volume":"279","author":"Park","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7269","key":"10.1016\/bs.acc.2017.12.002_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature08512","article-title":"HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses","volume":"462","author":"Yanai","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0125","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2012.01.040","article-title":"Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction","volume":"221","author":"Hashimoto","year":"2012","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcin.2010.10.015","article-title":"Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction","volume":"4","author":"Sorensen","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.atherosclerosis.2009.07.025","article-title":"Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction","volume":"208","author":"Giallauria","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2796.2011.02369.x","article-title":"HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction","volume":"270","author":"Andrassy","year":"2011","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cardfail.2008.11.010","article-title":"Increased high mobility group box-1 protein levels are associated with impaired cardiopulmonary and echocardiographic findings after acute myocardial infarction","volume":"15","author":"Cirillo","year":"2009","journal-title":"J. Card. Fail."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0150","first-page":"155","article-title":"P2X7 receptor at the heart of disease","volume":"14","author":"Vasileiou Ei","year":"2010","journal-title":"Hippokratia"},{"key":"10.1016\/bs.acc.2017.12.002_bb0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mvr.2015.11.005","article-title":"Ischemia triggered ATP release through Pannexin-1 channel by myocardial cells activates sympathetic fibers","volume":"104","author":"Dong","year":"2016","journal-title":"Microvasc. Res."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0160","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1164\/rccm.201003-0359OC","article-title":"Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis","volume":"182","author":"Riteau","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/bs.acc.2017.12.002_bb0165","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1038\/ncomms10555","article-title":"Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1beta secretion in response to ATP","volume":"7","author":"Karmakar","year":"2016","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tips.2007.07.002","article-title":"Liaisons dangereuses: P2X(7) and the inflammasome","volume":"28","author":"Di Virgilio","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1074\/jbc.M006781200","article-title":"Altered cytokine production in mice lacking P2X(7) receptors","volume":"276","author":"Solle","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0180","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pharmthera.2005.04.013","article-title":"Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation","volume":"112","author":"Bours","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb0185","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/cmi.12001","article-title":"P2X7 receptor regulation of non-classical secretion from immune effector cells","volume":"14","author":"Dubyak","year":"2012","journal-title":"Cell. Microbiol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2017_59","article-title":"The P2X7 receptor","volume":"1051","author":"Sluyter","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"12","key":"10.1016\/bs.acc.2017.12.002_bb0195","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.4049\/jimmunol.168.12.6436","article-title":"Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response","volume":"168","author":"Labasi","year":"2002","journal-title":"J. Immunol."},{"issue":"7285","key":"10.1016\/bs.acc.2017.12.002_bb0200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2012.04.047","article-title":"Increased circulating mitochondrial DNA after myocardial infarction","volume":"158","author":"Bliksoen","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yrtph.2017.07.028","article-title":"Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway","volume":"89","author":"Xie","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00395-016-0553-6","article-title":"Extracellular mtDNA activates NF-kappaB via toll-like receptor 9 and induces cell death in cardiomyocytes","volume":"111","author":"Bliksoen","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-016-0241-x","article-title":"The level of free circulating mitochondrial DNA in blood as predictor of death in case of acute coronary syndrome","volume":"22","author":"Sudakov","year":"2017","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/bs.acc.2017.12.002_bb0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-3-319-55330-6_19","article-title":"Peripheral blood mitochondrial DNA and myocardial function","volume":"982","author":"Kuznetsova","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0230","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/MCA.0000000000000231","article-title":"Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients","volume":"26","author":"Wang","year":"2015","journal-title":"Coron. Artery Dis."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0235","first-page":"224","article-title":"Release of mitochondrial DNA correlates with peak inflammatory cytokines in patients with acute myocardial infarction","volume":"17","author":"Qin","year":"2017","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0240","doi-asserted-by":"crossref","first-page":"206039","DOI":"10.1155\/2013\/206039","article-title":"Danger signals in the initiation of the inflammatory response after myocardial infarction","volume":"2013","author":"de Haan","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0245","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/cvr\/cvt047","article-title":"Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes","volume":"98","author":"Tian","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0250","doi-asserted-by":"crossref","first-page":"H2805","DOI":"10.1152\/ajpheart.00299.2008","article-title":"Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion","volume":"294","author":"Zou","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"36","key":"10.1016\/bs.acc.2017.12.002_bb0255","doi-asserted-by":"crossref","first-page":"31308","DOI":"10.1074\/jbc.M111.246124","article-title":"Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0260","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ymthe.2005.08.002","article-title":"S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction","volume":"12","author":"Pleger","year":"2005","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0265","doi-asserted-by":"crossref","first-page":"778","DOI":"10.15252\/emmm.201303498","article-title":"S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4","volume":"6","author":"Rohde","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"12","key":"10.1016\/bs.acc.2017.12.002_bb0270","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/CIRCULATIONAHA.106.622415","article-title":"Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction","volume":"114","author":"Most","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0275","doi-asserted-by":"crossref","first-page":"H1457","DOI":"10.1152\/ajpheart.00088.2008","article-title":"Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction","volume":"296","author":"Desjardins","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0280","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000683","article-title":"Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury","volume":"3","author":"Chen","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0285","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1160\/TH14-06-0507","article-title":"Regulation of monocyte\/macrophage polarisation by extracellular RNA","volume":"113","author":"Cabrera-Fuentes","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0290","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCULATIONAHA.113.002562","article-title":"Role of extracellular RNA in atherosclerotic plaque formation in mice","volume":"129","author":"Simsekyilmaz","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb0295","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1096\/fj.08-121608","article-title":"Signaling mechanism of extracellular RNA in endothelial cells","volume":"23","author":"Fischer","year":"2009","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb0300","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1182\/blood-2006-08-040691","article-title":"Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor","volume":"110","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0305","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1160\/th14-08-0703","article-title":"RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-alpha in cardiac ischaemia\/reperfusion injury","volume":"112","author":"Cabrera-Fuentes","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006049","article-title":"Signaling in innate immunity and inflammation","volume":"4","author":"Newton","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0315","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fphys.2014.00496","article-title":"Ischemia\/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor","volume":"5","author":"Vilahur","year":"2014","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0320","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00995.2008","article-title":"Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart","volume":"296","author":"Chao","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"23","key":"10.1016\/bs.acc.2017.12.002_bb0325","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1161\/01.CIR.0000101921.93016.1C","article-title":"Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction","volume":"108","author":"Shishido","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0330","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/ATVBAHA.107.140723","article-title":"Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction","volume":"27","author":"Favre","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0335","doi-asserted-by":"crossref","first-page":"H1311","DOI":"10.1152\/ajpheart.00119.2008","article-title":"Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice","volume":"295","author":"Feng","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0340","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jtcvs.2003.11.036","article-title":"Toll-like receptor 4 mediates ischemia\/reperfusion injury of the heart","volume":"128","author":"Chong","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/bs.acc.2017.12.002_bb0345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6793-7-5","article-title":"Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function","volume":"7","author":"Kim","year":"2007","journal-title":"BMC Physiol."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0350","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","article-title":"Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice","volume":"109","author":"Oyama","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb0355","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.4049\/jimmunol.180.10.6954","article-title":"Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice","volume":"180","author":"Riad","year":"2008","journal-title":"J. Immunol."},{"issue":"1 Suppl","key":"10.1016\/bs.acc.2017.12.002_bb0360","first-page":"I270","article-title":"Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury","volume":"114","author":"Shimamoto","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0365","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCRESAHA.107.158220","article-title":"Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction","volume":"102","author":"Timmers","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0370","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbadis.2013.10.006","article-title":"Toll-like receptor 3 plays a role in myocardial infarction and ischemia\/reperfusion injury","volume":"1842","author":"Lu","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb0375","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.RES.0000144175.70140.8c","article-title":"Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia","volume":"95","author":"Tavener","year":"2004","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/bs.acc.2017.12.002_bb0380","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tibs.2011.08.008","article-title":"RAGE: a single receptor fits multiple ligands","volume":"36","author":"Fritz","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb0385","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.cellsig.2013.06.013","article-title":"Cellular signalling of the receptor for advanced glycation end products (RAGE)","volume":"25","author":"Xie","year":"2013","journal-title":"Cell. Signal."},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb0390","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"issue":"6784","key":"10.1016\/bs.acc.2017.12.002_bb0395","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/35012626","article-title":"Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases","volume":"405","author":"Taguchi","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0400","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10719-016-9679-x","article-title":"Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions","volume":"33","author":"Neviere","year":"2016","journal-title":"Glycoconj. J."},{"key":"10.1016\/bs.acc.2017.12.002_bb0405","doi-asserted-by":"crossref","DOI":"10.1017\/S146239940900101X","article-title":"The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease","volume":"11","author":"Yan","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"issue":"8","key":"10.1016\/bs.acc.2017.12.002_bb0410","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/CIRCRESAHA.107.165308","article-title":"Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products","volume":"102","author":"Chang","year":"2008","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb0415","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2337\/db07-0326","article-title":"RAGE and modulation of ischemic injury in the diabetic myocardium","volume":"57","author":"Bucciarelli","year":"2008","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb0420","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/CIRCULATIONAHA.105.575993","article-title":"Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury","volume":"113","author":"Bucciarelli","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0425","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00395-015-0509-2","article-title":"Cardioprotective function of mitochondrial-targeted and transcriptionally inactive STAT3 against ischemia and reperfusion injury","volume":"110","author":"Szczepanek","year":"2015","journal-title":"Basic Res. Cardiol."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0430","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00395-010-0124-1","article-title":"Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia\/reperfusion","volume":"105","author":"Boengler","year":"2010","journal-title":"Basic Res. Cardiol."},{"issue":"5915","key":"10.1016\/bs.acc.2017.12.002_bb0435","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.1164551","article-title":"Function of mitochondrial Stat3 in cellular respiration","volume":"323","author":"Wegrzyn","year":"2009","journal-title":"Science"},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb0440","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI0215650","article-title":"What does Stat3 do?","volume":"109","author":"Levy","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010092","article-title":"RAGE modulates hypoxia\/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways","volume":"5","author":"Shang","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0450","doi-asserted-by":"crossref","first-page":"H1823","DOI":"10.1152\/ajpheart.01210.2007","article-title":"RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model","volume":"294","author":"Aleshin","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0455","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.redox.2015.01.008","article-title":"NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases","volume":"4","author":"Abderrazak","year":"2015","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0460","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0465","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2017.00123","article-title":"The P2X7 receptor-interleukin-1 liaison","volume":"8","author":"Giuliani","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0470","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tcb.2014.12.009","article-title":"Mechanisms of inflammasome activation: recent advances and novel insights","volume":"25","author":"Vanaja","year":"2015","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0475","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0480","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","article-title":"Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation","volume":"39","author":"Iyer","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0485","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1536\/ihj.13-388","article-title":"NLRP3 inflammasome as a novel player in myocardial infarction","volume":"55","author":"Takahashi","year":"2014","journal-title":"Int. Heart J."},{"key":"10.1016\/bs.acc.2017.12.002_bb0490","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijcard.2016.02.043","article-title":"Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse","volume":"209","author":"Toldo","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0000000000000247","article-title":"Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse","volume":"66","author":"Marchetti","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0500","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"issue":"49","key":"10.1016\/bs.acc.2017.12.002_bb0505","doi-asserted-by":"crossref","first-page":"19725","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse","volume":"108","author":"Mezzaroma","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"51","key":"10.1016\/bs.acc.2017.12.002_bb0510","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","article-title":"NF-kappaB and the immune response","volume":"25","author":"Hayden","year":"2006","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb0515","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0520","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.yjmcc.2006.07.006","article-title":"Regulating the regulator: NF-kappaB signaling in heart","volume":"41","author":"Hall","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0525","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.phrs.2008.06.007","article-title":"The immune system and cardiac repair","volume":"58","author":"Frangogiannis","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0530","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0735-1097(01)01377-8","article-title":"Nuclear factor kappa-B and the heart","volume":"38","author":"Valen","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0535","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.0105-2896.2006.00375.x","article-title":"Circuitry of nuclear factor kappaB signaling","volume":"210","author":"Hoffmann","year":"2006","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb0540","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb0545","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0028-1083786","article-title":"Complement activation and cardiovascular disease","volume":"40","author":"Bjerre","year":"2008","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0550","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molimm.2014.06.036","article-title":"A vital role for complement in heart disease","volume":"61","author":"Lappegard","year":"2014","journal-title":"Mol. Immunol."},{"issue":"9\u201310","key":"10.1016\/bs.acc.2017.12.002_bb0555","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0898-6568(00)00111-X","article-title":"Complement activation in heart diseases. Role of oxidants","volume":"12","author":"Chakraborti","year":"2000","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0560","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.CIR.81.1.156","article-title":"The complement system in ischemic heart disease","volume":"81","author":"Yasuda","year":"1990","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0565","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0463.2005.apm1130303.x","article-title":"Complement activation in acute coronary syndromes","volume":"113","author":"Iltumur","year":"2005","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0570","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1365-3083.2000.00783.x","article-title":"Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction","volume":"52","author":"Vakeva","year":"2000","journal-title":"Scand. J. Immunol."},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb0575","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/00063030-200115090-00004","article-title":"Role of the complement system in ischaemic heart disease: potential for pharmacological intervention","volume":"15","author":"Shernan","year":"2001","journal-title":"BioDrugs"},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb0580","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.0000087447.12918.85","article-title":"Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial","volume":"108","author":"Granger","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb0585","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/01.CIR.0000087404.53661.F8","article-title":"Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial","volume":"108","author":"Mahaffey","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0590","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.athoracsur.2003.08.054","article-title":"Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass","volume":"77","author":"Shernan","year":"2004","journal-title":"Ann. Thorac. Surg."},{"issue":"19","key":"10.1016\/bs.acc.2017.12.002_bb0595","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.291.19.2319","article-title":"Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial","volume":"291","author":"Verrier","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0600","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jtcvs.2005.10.019","article-title":"Inhibition of complement activation in cardiac surgery","volume":"131","author":"Sellke","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0605","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.1.43","article-title":"Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial","volume":"297","author":"Investigators","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0610","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Droge","year":"2002","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0615","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI200524408","article-title":"Oxygen, oxidative stress, hypoxia, and heart failure","volume":"115","author":"Giordano","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb0620","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb0625","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/ars.2011.4123","article-title":"Redox regulation of mitochondrial function","volume":"16","author":"Handy","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0630","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","article-title":"Reactive oxygen species in cardiovascular disease","volume":"51","author":"Sugamura","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0635","doi-asserted-by":"crossref","first-page":"H1778","DOI":"10.1152\/ajpheart.00796.2000","article-title":"Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of ICAM-1 in reperfused canine heart","volume":"282","author":"Fan","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0640","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fphys.2014.00352","article-title":"Reactive oxygen species at the crossroads of inflammasome and inflammation","volume":"5","author":"Harijith","year":"2014","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0645","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4049\/jimmunol.165.2.1013","article-title":"Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin","volume":"165","author":"Chandel","year":"2000","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0650","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.20110367","article-title":"Mitochondrial reactive oxygen species drive proinflammatory cytokine production","volume":"208","author":"Naik","year":"2011","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0655","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0002-9440(10)62517-5","article-title":"Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia","volume":"159","author":"Lakshminarayanan","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0660","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/08830185.2012.755176","article-title":"Reactive oxygen species in the immune system","volume":"32","author":"Yang","year":"2013","journal-title":"Int. Rev. Immunol."},{"issue":"22","key":"10.1016\/bs.acc.2017.12.002_bb0665","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1007\/s00018-009-0150-z","article-title":"Redox-sensitivity of the dimerization of occludin","volume":"66","author":"Walter","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/bs.acc.2017.12.002_bb0670","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.2009.04058.x","article-title":"The oligomerization of the coiled coil-domain of occludin is redox sensitive","volume":"1165","author":"Walter","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Pt. 1","key":"10.1016\/bs.acc.2017.12.002_bb0675","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1242\/jcs.022681","article-title":"Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration","volume":"121","author":"Turowski","year":"2008","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0680","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jcp.1041620118","article-title":"Differential effects of superoxide, hydrogen peroxide, and hydroxyl radical on intracellular calcium in human endothelial cells","volume":"162","author":"Dreher","year":"1995","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0685","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2006.09.030","article-title":"Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function","volume":"42","author":"Fialkow","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb0690","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.98.7.699","article-title":"Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia\/reperfusion","volume":"98","author":"Frangogiannis","year":"1998","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/bs.acc.2017.12.002_bb0695","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.94.15.8093","article-title":"Characterization of tumor necrosis factor-deficient mice","volume":"94","author":"Marino","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb0700","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1073\/pnas.070036297","article-title":"Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction","volume":"97","author":"Kurrelmeyer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/bs.acc.2017.12.002_bb0705","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/01.CIR.97.14.1375","article-title":"Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha","volume":"97","author":"Bryant","year":"1998","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb0710","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/hc3401.093154","article-title":"Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor","volume":"104","author":"Sivasubramanian","year":"2001","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/bs.acc.2017.12.002_bb0715","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1006\/jmcc.1999.0989","article-title":"Cellular basis for the acute inhibitory effects of IL-6 and TNF-alpha on excitation-contraction coupling","volume":"31","author":"Sugishita","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"14","key":"10.1016\/bs.acc.2017.12.002_bb0720","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/01.CIR.97.14.1382","article-title":"Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats","volume":"97","author":"Bozkurt","year":"1998","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/bs.acc.2017.12.002_bb0725","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1161\/01.CIR.102.22.2758","article-title":"Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production","volume":"102","author":"Grandel","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0730","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10741-010-9180-8","article-title":"TNFalpha in myocardial ischemia\/reperfusion, remodeling and heart failure","volume":"16","author":"Kleinbongard","year":"2011","journal-title":"Heart Fail. Rev."},{"issue":"18","key":"10.1016\/bs.acc.2017.12.002_bb0735","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","article-title":"Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0740","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055477","article-title":"Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction","volume":"8","author":"Nilsson","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb0745","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00392-012-0465-x","article-title":"TNF-alpha, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention","volume":"101","author":"Kehmeier","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0750","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2015.12.022","article-title":"Knockdown of TNF-alpha by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction","volume":"83","author":"Somasuntharam","year":"2016","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0755","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0760","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb0765","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1515\/BC.2002.178","article-title":"The TNF-TNF receptor system","volume":"383","author":"Hehlgans","year":"2002","journal-title":"Biol. Chem."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0770","doi-asserted-by":"crossref","first-page":"H1723","DOI":"10.1152\/ajpheart.00553.2011","article-title":"Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures","volume":"301","author":"Sanada","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0775","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00395-008-0732-1","article-title":"Reduced calcium responsiveness characterizes contractile dysfunction following coronary microembolization","volume":"103","author":"Skyschally","year":"2008","journal-title":"Basic Res. Cardiol."},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb0780","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurheartj\/ehi751","article-title":"Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization","volume":"27","author":"Canton","year":"2006","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0785","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00005-009-0024-y","article-title":"The role of IL-1 in the pathogenesis of heart disease","volume":"57","author":"Bujak","year":"2009","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0790","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.1401948","article-title":"Cutting edge: IL-1alpha is a crucial danger signal triggering acute myocardial inflammation during myocardial infarction","volume":"194","author":"Lugrin","year":"2015","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb0795","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.1300725","article-title":"IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium","volume":"191","author":"Saxena","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2013.06.002","article-title":"Effects of interleukin-1 on cardiac fibroblast function: relevance to post-myocardial infarction remodelling","volume":"60","author":"Turner","year":"2014","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/bs.acc.2017.12.002_bb0805","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-032414-112306","article-title":"Inflammasome-independent regulation of IL-1-family cytokines","volume":"33","author":"Netea","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0810","doi-asserted-by":"crossref","DOI":"10.15190\/d.2015.33","article-title":"Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational concepts","volume":"3","author":"Frangogiannis","year":"2015","journal-title":"Discoveries (Craiova)"},{"key":"10.1016\/bs.acc.2017.12.002_bb0815","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2013.11.015","article-title":"Fibroblasts in myocardial infarction: a role in inflammation and repair","volume":"70","author":"Shinde","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0820","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2353\/ajpath.2008.070974","article-title":"Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling","volume":"173","author":"Bujak","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0825","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2796.2012.02517.x","article-title":"Increased interleukin-1beta levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention","volume":"272","author":"Orn","year":"2012","journal-title":"J. Intern. Med."},{"issue":"20","key":"10.1016\/bs.acc.2017.12.002_bb0830","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1161\/CIRCULATIONAHA.107.740233","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction","volume":"117","author":"Abbate","year":"2008","journal-title":"Circulation"},{"issue":"12 Suppl. 1","key":"10.1016\/bs.acc.2017.12.002_bb0835","article-title":"Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0840","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2015.07.004","article-title":"Interleukin-6: biology, signaling and strategies of blockade","volume":"26","author":"Schaper","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"15","key":"10.1016\/bs.acc.2017.12.002_bb0845","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2174\/138161209788186290","article-title":"Cardiovascular biology of interleukin-6","volume":"15","author":"Abeywardena","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0850","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.181.3.2189","article-title":"IL-6 regulates neutrophil trafficking during acute inflammation via STAT3","volume":"181","author":"Fielding","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb0855","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/01.CIR.99.4.546","article-title":"Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions","volume":"99","author":"Gwechenberger","year":"1999","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0860","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003014","article-title":"Circulating levels of IL-6 receptor and gp130 and long-term clinical outcomes in ST-elevation myocardial infarction","volume":"5","author":"Ritschel","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb0865","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00011-004-1298-5","article-title":"Chemokines in the ischemic myocardium: from inflammation to fibrosis","volume":"53","author":"Frangogiannis","year":"2004","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0870","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tcm.2005.06.005","article-title":"Chemokines in myocardial ischemia","volume":"15","author":"Frangogiannis","year":"2005","journal-title":"Trends Cardiovasc. Med."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0875","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.106.646091","article-title":"Critical role of monocyte chemoattractant protein-1\/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy","volume":"115","author":"Frangogiannis","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/bs.acc.2017.12.002_bb0880","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.RES.0000246113.82111.2d","article-title":"Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction","volume":"99","author":"Morimoto","year":"2006","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0885","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.resp.2013.02.023","article-title":"Life of neutrophil: from stem cell to neutrophil extracellular trap","volume":"187","author":"Pruchniak","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"8","key":"10.1016\/bs.acc.2017.12.002_bb0890","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0895","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nri3800","article-title":"Role of innate and adaptive immune mechanisms in cardiac injury and repair","volume":"15","author":"Epelman","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0900","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"Frangogiannis","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb0905","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tcb.2005.09.002","article-title":"Inflammatory cells during wound repair: the good, the bad and the ugly","volume":"15","author":"Martin","year":"2005","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0910","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-0037-1613537","article-title":"Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle","volume":"89","author":"Chavakis","year":"2003","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/bs.acc.2017.12.002_bb0915","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V95.8.2459","article-title":"Introduction: functional polarity of motile neutrophils","volume":"95","author":"Smith","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb0920","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.20051210","article-title":"Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils","volume":"203","author":"Wang","year":"2006","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb0925","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.it.2011.06.009","article-title":"Emerging mechanisms of neutrophil recruitment across endothelium","volume":"32","author":"Williams","year":"2011","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb0930","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.4049\/jimmunol.1203179","article-title":"Integrin regulation during leukocyte recruitment","volume":"190","author":"Herter","year":"2013","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/bs.acc.2017.12.002_bb0935","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1084\/jem.20060925","article-title":"Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade","volume":"203","author":"Phillipson","year":"2006","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0940","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1440-1711.2001.01020.x","article-title":"Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited","volume":"79","author":"Lefkowitz","year":"2001","journal-title":"Immunol. Cell Biol."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0945","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00705-009-0371-3","article-title":"Neutrophil survival factors (TNF-alpha, GM-CSF, and G-CSF) produced by macrophages in cats infected with feline infectious peritonitis virus contribute to the pathogenesis of granulomatous lesions","volume":"154","author":"Takano","year":"2009","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb0950","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/cimm.2000.1638","article-title":"The endothelium and cytokine secretion: the role of peroxidases as immunoregulators","volume":"202","author":"Lefkowitz","year":"2000","journal-title":"Cell. Immunol."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0955","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.186.5.739","article-title":"Identification of human neutrophil-derived cathepsin G and azurocidin\/CAP37 as chemoattractants for mononuclear cells and neutrophils","volume":"186","author":"Chertov","year":"1997","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb0960","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.immuni.2004.07.006","article-title":"Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus","volume":"21","author":"Tsuda","year":"2004","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb0965","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.4049\/jimmunol.171.11.6052","article-title":"Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection","volume":"171","author":"Bennouna","year":"2003","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/bs.acc.2017.12.002_bb0970","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.20041276","article-title":"Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN","volume":"201","author":"van Gisbergen","year":"2005","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb0975","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.intimp.2010.08.012","article-title":"Neutrophils: Cinderella of innate immune system","volume":"10","author":"Kumar","year":"2010","journal-title":"Int. Immunopharmacol."},{"issue":"29","key":"10.1016\/bs.acc.2017.12.002_bb0980","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/eurheartj\/ehv195","article-title":"Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humans","volume":"36","author":"Ruparelia","year":"2015","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb0985","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11897-015-0255-7","article-title":"Cellular immunity and cardiac remodeling after myocardial infarction: role of neutrophils, monocytes, and macrophages","volume":"12","author":"Shinagawa","year":"2015","journal-title":"Curr. Heart Fail. Rep."},{"issue":"Suppl. 1","key":"10.1016\/bs.acc.2017.12.002_bb0990","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.21037\/jtd.2016.11.17","article-title":"Monocytes and macrophages in cardiac injury and repair","volume":"9","author":"Sager","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb0995","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/ATVBAHA.114.304652","article-title":"Monocytes in myocardial infarction","volume":"35","author":"Dutta","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb1000","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb1005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvu025","article-title":"Cardiac macrophages and their role in ischaemic heart disease","volume":"102","author":"Frantz","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/bs.acc.2017.12.002_bb1010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yjmcc.2015.11.002","article-title":"Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)","volume":"94","author":"Turner","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb1015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001993","article-title":"Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo","volume":"4","author":"Zhang","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.vph.2012.07.003","article-title":"The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction","volume":"58","author":"van Nieuwenhoven","year":"2013","journal-title":"Vascul. Pharmacol."},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb1025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20110561","article-title":"Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction","volume":"123","author":"Kretzschmar","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb1030","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.111.052126","article-title":"Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling","volume":"125","author":"Anzai","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb1035","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s12265-012-9410-7","article-title":"Communication in the heart: the role of the innate immune system in coordinating cellular responses to ischemic injury","volume":"5","author":"Epelman","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb1040","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1161\/ATVBAHA.112.254409","article-title":"The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction","volume":"32","author":"Cochain","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1045","first-page":"187","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb1050","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nm.3778","article-title":"Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction","volume":"21","author":"Korf-Klingebiel","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/bs.acc.2017.12.002_bb1055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yjmcc.2015.11.015","article-title":"Monocyte and macrophage contributions to cardiac remodeling","volume":"93","author":"Hulsmans","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb1060","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/CIRCRESAHA.114.303204","article-title":"Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium","volume":"114","author":"Hilgendorf","year":"2014","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/bs.acc.2017.12.002_bb1065","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1161\/CIRCULATIONAHA.111.044164","article-title":"Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice","volume":"125","author":"Hofmann","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2017.12.002_bb1070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yjmcc.2013.06.004","article-title":"Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates myocardial ischemia\/reperfusion injury in mice","volume":"62","author":"Homma","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb1075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nm.3816","article-title":"Myocardial healing requires Reg3beta-dependent accumulation of macrophages in the ischemic heart","volume":"21","author":"Lorchner","year":"2015","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb1080","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jacc.2006.07.060","article-title":"The role of platelet-derived growth factor signaling in healing myocardial infarcts","volume":"48","author":"Zymek","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb1085","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb1090","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/CIRCRESAHA.111.262477","article-title":"Identification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6- interleukin-10+ cytokine patterns in ST-elevation acute myocardial infarction","volume":"111","author":"Ammirati","year":"2012","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1095","first-page":"159","article-title":"Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes","volume":"1","author":"Carey","year":"2012","journal-title":"JAKSTAT"},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cardiores.2004.07.017","article-title":"Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction","volume":"64","author":"Ikeuchi","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb1105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.2354","article-title":"GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice","volume":"17","author":"Kempf","year":"2011","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/bs.acc.2017.12.002_bb1110","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehm465","article-title":"Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction","volume":"28","author":"Kempf","year":"2007","journal-title":"Eur. Heart J."},{"issue":"7503","key":"10.1016\/bs.acc.2017.12.002_bb1115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb1120","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1038\/s41598-017-10441-8","article-title":"Resolution agonist 15-epi-lipoxin A4 programs early activation of resolving phase in post-myocardial infarction healing","volume":"7","author":"Kain","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2017.12.002_bb1125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2015.04.003","article-title":"Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function","volume":"84","author":"Kain","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb1130","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2353\/ajpath.2010.090759","article-title":"CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells","volume":"176","author":"Dobaczewski","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb1135","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/ATVBAHA.112.300310","article-title":"Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts","volume":"32","author":"Chen","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb1140","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbamcr.2012.08.023","article-title":"Fibroblasts in post-infarction inflammation and cardiac repair","volume":"1833","author":"Chen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb1145","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCRESAHA.110.224428","article-title":"Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction","volume":"108","author":"Arslan","year":"2011","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb1150","doi-asserted-by":"crossref","first-page":"H323","DOI":"10.1152\/ajpheart.00321.2005","article-title":"Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling","volume":"290","author":"Naugle","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCRESAHA.107.160408","article-title":"Osteopontin expression is required for myofibroblast differentiation","volume":"102","author":"Lenga","year":"2008","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb1160","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/HYPERTENSIONAHA.111.175323","article-title":"Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism","volume":"58","author":"Xia","year":"2011","journal-title":"Hypertension"},{"issue":"Pt. 10","key":"10.1016\/bs.acc.2017.12.002_bb1165","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1242\/jcs.001586","article-title":"Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway","volume":"120","author":"Zhao","year":"2007","journal-title":"J. Cell Sci."},{"issue":"22","key":"10.1016\/bs.acc.2017.12.002_bb1170","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/CIRCULATIONAHA.104.510354","article-title":"Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts","volume":"111","author":"Frangogiannis","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb1175","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/hh1001.090842","article-title":"Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin","volume":"88","author":"Trueblood","year":"2001","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1180","doi-asserted-by":"crossref","first-page":"H1072","DOI":"10.1152\/ajpheart.00255.2009","article-title":"Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice","volume":"298","author":"Nishioka","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"24","key":"10.1016\/bs.acc.2017.12.002_bb1185","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/01.CIR.98.24.2765","article-title":"Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo","volume":"98","author":"McEwan","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb1190","doi-asserted-by":"crossref","first-page":"H176","DOI":"10.1152\/ajpheart.00421.2002","article-title":"Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1\/2 signaling","volume":"284","author":"Stockand","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"14","key":"10.1016\/bs.acc.2017.12.002_bb1195","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/bs.acc.2017.12.002_bb1200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb1205","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.yjmcc.2011.06.023","article-title":"Platelet-derived growth factor involvement in myocardial remodeling following infarction","volume":"51","author":"Zhao","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb1210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097281","article-title":"High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling","volume":"9","author":"Santiago","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/bs.acc.2017.12.002_bb1215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11010-007-9676-2","article-title":"Chymase induces profibrotic response via transforming growth factor-beta 1\/Smad activation in rat cardiac fibroblasts","volume":"310","author":"Zhao","year":"2008","journal-title":"Mol. Cell. Biochem."},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb1220","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.RES.82.11.1130","article-title":"Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction","volume":"82","author":"Takemura","year":"1998","journal-title":"Circ. Res."},{"issue":"9932","key":"10.1016\/bs.acc.2017.12.002_bb1225","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","article-title":"Cardiovascular remodelling in coronary artery disease and heart failure","volume":"383","author":"Heusch","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb1230","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb1235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0735-1097(88)90159-3","article-title":"Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis","volume":"11","author":"Warren","year":"1988","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1240","doi-asserted-by":"crossref","first-page":"H976","DOI":"10.1152\/ajpheart.2000.279.3.H976","article-title":"Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy","volume":"279","author":"Modesti","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9507","key":"10.1016\/bs.acc.2017.12.002_bb1245","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb1250","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.CIR.74.4.693","article-title":"Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion","volume":"74","author":"McKay","year":"1986","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/bs.acc.2017.12.002_bb1255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11886-017-0876-4","article-title":"Adverse remodeling and reverse remodeling after myocardial infarction","volume":"19","author":"Bhatt","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"issue":"4","key":"10.1016\/bs.acc.2017.12.002_bb1260","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cardiores.2003.12.005","article-title":"Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse","volume":"61","author":"Mori","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/bs.acc.2017.12.002_bb1265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/bs.acc.2017.12.002_bb1270","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.CIR.97.9.892","article-title":"Expression of Gq\u03b1 and PLC-\u03b2 in scar and border tissue in heart failure due to myocardial infarction","volume":"97","author":"Ju","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.acc.2017.12.002_bb1275","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/01.RES.78.6.954","article-title":"Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes","volume":"78","author":"Glennon","year":"1996","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/bs.acc.2017.12.002_bb1280","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","article-title":"Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms","volume":"107","author":"Hein","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1285","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.ijcard.2013.01.004","article-title":"Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy","volume":"168","author":"van Diepen","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb1290","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.98.2.149","article-title":"Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling","volume":"98","author":"Ono","year":"1998","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/bs.acc.2017.12.002_bb1295","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1300","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/oxfordjournals.eurheartj.a015268","article-title":"Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure","volume":"18","author":"Devaux","year":"1997","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb1305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","article-title":"Fibrosis and heart failure","volume":"19","author":"Segura","year":"2014","journal-title":"Heart Fail. Rev."},{"issue":"3","key":"10.1016\/bs.acc.2017.12.002_bb1310","doi-asserted-by":"crossref","first-page":"H1015","DOI":"10.1152\/ajpheart.00023.2006","article-title":"Cardiac fibroblasts: friend or foe?","volume":"291","author":"Baudino","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/bs.acc.2017.12.002_bb1315","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.atherosclerosis.2010.06.022","article-title":"Atherosclerosis and leukocyte-endothelial adhesive interactions are increased following acute myocardial infarction in apolipoprotein E deficient mice","volume":"212","author":"Wright","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/bs.acc.2017.12.002_bb1320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2013.04.004","article-title":"Acute myocardial infarction leads to acceleration of atherosclerosis","volume":"229","author":"Wang","year":"2013","journal-title":"Atherosclerosis"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242317300677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242317300677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:35:15Z","timestamp":1758742515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242317300677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128152065"],"references-count":263,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2017.12.002","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}